We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Testing Pregnant Mothers Prevents Congenital Syphilis

By LabMedica International staff writers
Posted on 20 Jun 2011
Congenital syphilis is easily prevented by testing mothers while they are pregnant. More...


Testing should occur at the first prenatal visit and in communities where the risk is high; it should be repeated during the third trimester and once more at delivery. Mothers who are diagnosed with syphilis during pregnancy can be treated to prevent syphilis infection of the baby.

Syphilis is caused by the sexually transmitted bacteria known as Treponema pallidum. Sexually transmitted diseases (STDs) including syphilis, chlamydia, gonorrhea, herpes, human papillomavirus (HPV), and human immunodeficiency virus (HIV) can be transmitted to infants during pregnancy.

A study of 41,000 women, published in the early online edition of the Lancet Infectious Diseases on June 16, 2011 showed that testing and antibiotics could more than halve the number of deaths of babies whose mothers were suffering from syphilis. The UK experts said screening was cheap and cost-effective.

The study was lead by Dr. S. Hawkes PhD, reader in global health, UCL Institute for Global Health and Center for International Health and Development, University College London (United Kingdom).

Congenital syphilis in infants can result in stillbirth, premature delivery, low birth weight, and significant birth defects (bone, blood, brain, heart). Syphilis causes 500,000 stillbirths and newborn deaths globally, mostly in Sub-Saharan Africa.

Related Links:

University College London




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.